N = 5 COVID-19 patients with ARDS, severe rapid progression pneumonia and continuously high viral load despite antiviral treatment  Intervention group: patients receiving CP (n = 5)  No control group. This evidence concerns the gene CP and acute respiratory distress syndrome.